![Sasha Austin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sasha Austin
Comptroller/Controller/Auditor bij
OLEMA PHARMACEUTICALS, INC.
Vermogen: 213 520 $ op 31-05-2026
Profiel
Sasha Austin currently works at The American Institute of Certified Public Accountants, as Member and Olema Pharmaceuticals, Inc., as Vice President-Finance & Controller from 2023.
Ms. Austin also formerly worked at GigCapital Global, as Controller from 2020 to 2021.
Ms. Austin received her undergraduate degree from Seattle University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-02-2026 | 16.188 ( 0,02% ) | 213 520 $ | 31-05-2026 |
Actieve functies van Sasha Austin
| Bedrijven | Functie | Begin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-04-2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Eerdere bekende functies van Sasha Austin
| Bedrijven | Functie | Einde |
|---|
Opleiding van Sasha Austin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Kies MarketScreener 
